| Tue, 07 Sep 2010 15:45:08 GMT |
| IRIS INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi |
|
|
| Tue, 07 Sep 2010 12:00:00 GMT |
| IRIS to Present at UBS Annual Global Life Sciences Conference |
|
[GlobeNewswire] - CHATSWORTH, Calif. -- IRIS International, Inc. , a leading manufacturer of automated in-vitro diagnostic systems and consumables for use in hospitals and commercial laboratories worldwide and provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that Chairman, President and Chief Executive Officer Cesar Garcia will present an overview of the Company at the UBS annual Global Life Sciences Conference at 2:30 p.m. |
| Tue, 07 Sep 2010 11:00:00 GMT |
| IRIS Receives FDA 510(k) Clearance for Analysis of Synovial Fluid Utilizing Its iQ(R)200 Series Automated Microscopy Analyzers |
|
[GlobeNewswire] - CHATSWORTH, Calif. -- IRIS International, Inc. , a leading manufacturer of automated in-vitro diagnostic systems and consumables for use in hospitals and commercial laboratories worldwide and provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that it has received 510 clearance from the U.S. |
| Thu, 02 Sep 2010 19:25:22 GMT |
| IRIS INTERNATIONAL INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Ba |
|
|
| Thu, 19 Aug 2010 15:33:02 GMT |
| IRIS INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits |
|
|